Stock analysts at StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of Bellerophon Therapeutics stock opened at $0.04 on Friday. Bellerophon Therapeutics has a 1 year low of $0.03 and a 1 year high of $0.42. The firm’s 50-day simple moving average is $0.04 and its 200-day simple moving average is $0.05. The firm has a market cap of $440,388.00, a PE ratio of -0.04 and a beta of 0.70.
Bellerophon Therapeutics Company Profile
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- Stock Sentiment Analysis: How it Works
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- How is Compound Interest Calculated?
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Election Stocks: How Elections Affect the Stock Market
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
